CPAP and measures of cardiovascular risk in males with OSAS.

CPAP and measures of cardiovascular risk in males with OSAS.

Obstructive sleep apnoea syndrome (OSAS) has been associated with hypertension, stroke and myocardial ischaemia in epidemiological and observational studies. Continuous positive airway pressure (CPAP) is the treatment of choice for OSAS, but the impact of this intervention on established risk factor...

Bibliografske podrobnosti
Main Authors:	Kohler, M, Pepperell, J, Casadei, B, Craig, S, Crosthwaite, N, Stradling, JR, Davies, R
Format:	Journal article
Jezik:	English
Izdano:	2008

Podobne knjige/članki

Blood pressure change after treatment for obstructive sleep apnoea (OSA) with continuous positive airway pressure (CPAP)
od: Pepperell, J, et al.
Izdano: (2000)

CPAP IMPROVES ENDOTHELIAL FUNCTION IN MINIMALLY SYMPTOMATIC OSA PATIENTS: RESULTS FROM THE MOSAIC TRIAL
od: Kohler, M, et al.
Izdano: (2010)

In minimally symptomatic OSA what is the best test to measure CPAP response?
od: Turnbull, C, et al.
Izdano: (2015)

Residual sleepiness in patients with OSA on CPAP.
od: Stradling, JR
Izdano: (2009)

Patterns of CPAP usage in patients with minimally symptomatic OSA
od: Turnbull, C, et al.
Izdano: (2015)

Cardiovascular Risk in Asymptomatic OSA
od: Kohler, M, et al.
Izdano: (2009)

CPAP improves endothelial function in patients with minimally symptomatic OSA: results from a subset study of the MOSAIC trial.
od: Kohler, M, et al.
Izdano: (2013)

Effect of CPAP on cardiovascular events in minimally symptomatic OSA: long-term follow-up of the MOSAIC randomised controlled trial
od: Tang, I, et al.
Izdano: (2020)

THE PRIMARY RESULTS OF THE MOSAIC TRIAL: DOES CPAP FOR MINIMALLY SYMPTOMATIC OSA REDUCE DAYTIME SLEEPINESS OR CALCULATED VASCULAR RISK?
od: Craig, SE, et al.
Izdano: (2010)

In patients with minimally symptomatic OSA can baseline characteristics and early patterns of CPAP usage predict those who are likely to be longer-term users of CPAP
od: Turnbull, CD, et al.
Izdano: (2016)

The effects of CPAP withdrawal in patients with OSA on hypoxia-induced markers
od: Turnbull, C, et al.
Izdano: (2016)

Paradoxical decrease in isoprostane and increase in superoxide dismutase following CPAP withdrawal in OSA.
od: Antoniades, C, et al.
Izdano: (2016)

Relative accuracy of algorithm-based prescription of nasal CPAP in OSA.
od: Stradling, JR, et al.
Izdano: (2004)

Effect of CPAP on cardiovascular events in minimally symptomatic OSA: long-term follow-up of the MOSAIC randomised controlled trial
od: John R Stradling, et al.
Izdano: (2020-09-01)

A novel, simplified approach to starting nasal CPAP therapy in OSA.
od: Stradling, JR, et al.
Izdano: (2004)

Baseline blood pressure and hypersomnolence predict bp fall with CPAP treatment of OSA
od: Robinson, G, et al.
Izdano: (2007)

EFFECT OF CPAP TREATMENT FOR OSA ON VISUAL PROCESSING OF DEGRADED WORDS
od: Proudlove, K, et al.
Izdano: (2012)

Blood pressure variability in OSA – data from four randomised-controlled CPAP-withdrawal trials
od: Lettau, F, et al.
Izdano: (2017)

Effect of CPAP withdrawal on myocardial perfusion in OSA - a randomized controlled trial
od: Schwarz, E, et al.
Izdano: (2016)

Can autonomic arousals and neural net EEG analysis predict daytime sleepiness and its response to nCPAP in OSA?
od: Bennett, L, et al.
Izdano: (1997)

Effect of CPAP-withdrawal on blood pressure in OSA: data from three randomized-controlled trials
od: Schwarz, E, et al.
Izdano: (2016)

Continuous positive airway pressure treatment for obstructive sleep apnoea reduces resting heart rate but does not affect dysrhythmias: a randomised controlled trial.
od: Craig, S, et al.
Izdano: (2009)

COVID-19 related changes in outpatient CPAP set-up pathways for OSA are linked with decreased 30-day CPAP usage
od: Turnbull, CD, et al.
Izdano: (2021)

Does either obesity or OSA severity influence the response of autotitrating CPAP machines in very obese subjects?
od: Turnbull, C, et al.
Izdano: (2015)

Effects of Overnight Supplemental Oxygen on Morning Blood Pressure in a Randomized Controlled CPAP Withdrawal Trial in Patients with OSA
od: Petousi, N, et al.
Izdano: (2018)

Effect of CPAP on depressive symptoms in OSA
od: Samy S. Eldahdouh, et al.
Izdano: (2014-04-01)

Effect of CPAP on cardiac function in minimally symptomatic patients with OSA: results from a subset of the MOSAIC randomized trial
od: Craig, S, et al.
Izdano: (2015)

CPAP increases bronchial reactivity in OSAS patients
od: P. Korczyski, et al.
Izdano: (2008-06-01)

Markers of inflammation: data from the MOSAIC randomised trial of CPAP for minimally symptomatic OSA
od: Craig, S, et al.
Izdano: (2014)

CrossTalk proposal: Most of the cardiovascular consequences of OSA are due to increased sympathetic activity.
od: Kohler, M, et al.
Izdano: (2012)

CrossTalk proposal: Most of the cardiovascular consequences of OSA are due to increased sympathetic activity
od: Kohler, M, et al.
Izdano: (2012)

Predictors of blood pressure fall with continuous positive airway pressure (CPAP) treatment of obstructive sleep apnoea (OSA).
od: Robinson, G, et al.
Izdano: (2008)

Platelet activation is increased in obstructive sleep apnoea and does not fall with CPAP treatment
od: Robinson, G, et al.
Izdano: (2002)

The interaction among OSA, CPAP, and medications in patients with comorbid OSA and cardiovascular/cerebrovascular disease: a randomized controlled trial
od: Miaochan Lao, et al.
Izdano: (2022-03-01)

Metabolic Sydrome Prediction in Mild/Moderate OSA Patients - Anthropometric Measures and Abdominal Fat Estimations by MRI
od: Craig, SE, et al.
Izdano: (2009)

EFFECT OF CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) ON DIURNAL SODIUM AND WATER-EXCRETION IN OBSTRUCTIVE SLEEP-APNEA (OSA)
od: Warley, A, et al.
Izdano: (1987)

Oximetry derivatives in the assessment of OSA
od: Bennett, L, et al.
Izdano: (1999)

OSA and hypertension: do we know all the answers?
od: Kohler, M, et al.
Izdano: (2013)

Baroreflex sensitivity increases after 4 weeks of nasal continuous positive airway presure therapy in patients with obstructive sleep apnoea
od: Pepperell, J, et al.
Izdano: (2001)

DIABETIC MACULAR OEDEMA (DME) AND OBSTRUCTIVE SLEEP APNOEA (OSA)-VISUAL IMPROVIEMENT POST CPAP THERAPY. PROOF OF PRINCIPLE STUDY
od: Mason, R, et al.
Izdano: (2010)